Similar articles

• Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.

  Couto JR, Blank EW, Peterson JA, Ceriani RL. Couto JR, et al. Hybridoma. 1993 Aug;12(4):485-9. doi: 10.1089/hyb.1993.12.485. Hybridoma. 1993. PMID: 8244420
• Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.

  Tonge DW, Hennam JF, Greene AR, Lee ID, Edge MD. Tonge DW, et al. Year Immunol. 1993;7:56-62. Year Immunol. 1993. PMID: 8372513 No abstract available.
• Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2.

  Liu HL, Parkes DL, Langton BC, Xuan JA, Longhi M, Elliger SS, Chao LA, McGrogan MP, Brandis JW, Shawver LK. Liu HL, et al. Biochem Biophys Res Commun. 1995 Jun 26;211(3):792-803. doi: 10.1006/bbrc.1995.1882. Biochem Biophys Res Commun. 1995. PMID: 7598708
• Engineering mouse monoclonal antibodies for cancer immunotherapy.

  Orlandi R. Orlandi R. Year Immunol. 1993;7:69-73. Year Immunol. 1993. PMID: 8372514 Review. No abstract available.
• Recombinant chimeric monoclonal antibodies.

  Morrison SL, Schlom J. Morrison SL, et al. Important Adv Oncol. 1990:3-18. Important Adv Oncol. 1990. PMID: 2182522 Review. No abstract available.